136 related articles for article (PubMed ID: 21907172)
1. Genetic suppression of atrial fibrillation using a dominant-negative ether-a-go-go-related gene mutant.
Soucek R; Thomas D; Kelemen K; Bikou O; Seyler C; Voss F; Becker R; Koenen M; Katus HA; Bauer A
Heart Rhythm; 2012 Feb; 9(2):265-72. PubMed ID: 21907172
[TBL] [Abstract][Full Text] [Related]
2. Connexin 43 gene therapy prevents persistent atrial fibrillation in a porcine model.
Bikou O; Thomas D; Trappe K; Lugenbiel P; Kelemen K; Koch M; Soucek R; Voss F; Becker R; Katus HA; Bauer A
Cardiovasc Res; 2011 Nov; 92(2):218-25. PubMed ID: 21799069
[TBL] [Abstract][Full Text] [Related]
3. Suppression of persistent atrial fibrillation by genetic knockdown of caspase 3: a pre-clinical pilot study.
Trappe K; Thomas D; Bikou O; Kelemen K; Lugenbiel P; Voss F; Becker R; Katus HA; Bauer A
Eur Heart J; 2013 Jan; 34(2):147-57. PubMed ID: 21785105
[TBL] [Abstract][Full Text] [Related]
4. Genetic suppression of Gαs protein provides rate control in atrial fibrillation.
Lugenbiel P; Thomas D; Kelemen K; Trappe K; Bikou O; Schweizer PA; Voss F; Becker R; Katus HA; Bauer A
Basic Res Cardiol; 2012 May; 107(3):265. PubMed ID: 22457123
[TBL] [Abstract][Full Text] [Related]
5. Selective molecular potassium channel blockade prevents atrial fibrillation.
Amit G; Kikuchi K; Greener ID; Yang L; Novack V; Donahue JK
Circulation; 2010 Jun; 121(21):2263-70. PubMed ID: 20479154
[TBL] [Abstract][Full Text] [Related]
6. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K
Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D
Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528
[TBL] [Abstract][Full Text] [Related]
7. TREK-1 (K
Lugenbiel P; Wenz F; Syren P; Geschwill P; Govorov K; Seyler C; Frank D; Schweizer PA; Franke J; Weis T; Bruehl C; Schmack B; Ruhparwar A; Karck M; Frey N; Katus HA; Thomas D
Basic Res Cardiol; 2017 Jan; 112(1):8. PubMed ID: 28005193
[TBL] [Abstract][Full Text] [Related]
8. Cardiac expression and atrial fibrillation-associated remodeling of K₂p2.1 (TREK-1) K⁺ channels in a porcine model.
Schmidt C; Wiedmann F; Tristram F; Anand P; Wenzel W; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
Life Sci; 2014 Mar; 97(2):107-15. PubMed ID: 24345461
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory G protein overexpression provides physiologically relevant heart rate control in persistent atrial fibrillation.
Bauer A; McDonald AD; Nasir K; Peller L; Rade JJ; Miller JM; Heldman AW; Donahue JK
Circulation; 2004 Nov; 110(19):3115-20. PubMed ID: 15505099
[TBL] [Abstract][Full Text] [Related]
10. The new selective I(Ks)-blocking agent HMR 1556 restores sinus rhythm and prevents heart failure in pigs with persistent atrial fibrillation.
Bauer A; Koch M; Kraft P; Becker R; Kelemen K; Voss F; Senges JC; Gerlach U; Katus HA; Schoels W
Basic Res Cardiol; 2005 May; 100(3):270-8. PubMed ID: 15795798
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological and antiarrhythmic effects of the novel I(Kur) channel blockers, S9947 and S20951, on left vs. right pig atrium in vivo in comparison with the I(Kr) blockers dofetilide, azimilide, d,l-sotalol and ibutilide.
Knobloch K; Brendel J; Peukert S; Rosenstein B; Busch AE; Wirth KJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):482-7. PubMed ID: 12382079
[TBL] [Abstract][Full Text] [Related]
13. Arrhythmic potency of human ether-a-go-go-related gene mutations L532P and N588K in a computational model of human atrial myocytes.
Loewe A; Wilhelms M; Fischer F; Scholz EP; Dössel O; Seemann G
Europace; 2014 Mar; 16(3):435-43. PubMed ID: 24569898
[TBL] [Abstract][Full Text] [Related]
14. Cloning, functional characterization, and remodeling of K2P3.1 (TASK-1) potassium channels in a porcine model of atrial fibrillation and heart failure.
Schmidt C; Wiedmann F; Langer C; Tristram F; Anand P; Wenzel W; Lugenbiel P; Schweizer PA; Katus HA; Thomas D
Heart Rhythm; 2014 Oct; 11(10):1798-805. PubMed ID: 24952150
[TBL] [Abstract][Full Text] [Related]
15. The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG).
Sinner MF; Pfeufer A; Akyol M; Beckmann BM; Hinterseer M; Wacker A; Perz S; Sauter W; Illig T; Näbauer M; Schmitt C; Wichmann HE; Schömig A; Steinbeck G; Meitinger T; Kääb S
Eur Heart J; 2008 Apr; 29(7):907-14. PubMed ID: 18222980
[TBL] [Abstract][Full Text] [Related]
16. Genetic modifier of the QTc interval associated with early-onset atrial fibrillation.
Andreasen L; Nielsen JB; Christophersen IE; Holst AG; Sajadieh A; Tveit A; Haunsø S; Svendsen JH; Schmitt N; Olesen MS
Can J Cardiol; 2013 Oct; 29(10):1234-40. PubMed ID: 24074973
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme-2 overexpression improves atrial remodeling and function in a canine model of atrial fibrillation.
Zhou T; Wang Z; Fan J; Chen S; Tan Z; Yang H; Yin Y
J Am Heart Assoc; 2015 Mar; 4(3):e001530. PubMed ID: 25792125
[TBL] [Abstract][Full Text] [Related]
18. Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.
Blaauw Y; Schotten U; van Hunnik A; Neuberger HR; Allessie MA
Cardiovasc Res; 2007 Jul; 75(1):89-98. PubMed ID: 17466958
[TBL] [Abstract][Full Text] [Related]
19. Targeted modification of atrial electrophysiology by homogeneous transmural atrial gene transfer.
Kikuchi K; McDonald AD; Sasano T; Donahue JK
Circulation; 2005 Jan; 111(3):264-70. PubMed ID: 15642761
[TBL] [Abstract][Full Text] [Related]
20. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
